|
FDA Approves Inhalable Diabetes Drug Afrezza
ABC News The Food and Drug Administration on Friday approved a long-delayed inhalable diabetes medication to help patients control their blood sugar levels during meals. The FDA cleared MannKind Corp.’s drug Afrezza, a fast-acting form of insulin, for adults with … UPDATE 1-US FDA approves MannKind’s diabetes therapy AfrezzaReuters MannKind Wins US FDA Approval for Inhaled InsulinBusinessweek FDA Approves MannKind’s Inhaled Insulin TreatmentWall Street Journal FDA.gov –FierceBiotech all 24 news articles |
Source: Business News From Google News